(Q77930168)
Statements
Open label study to assess infliximab safety and timing of onset of clinical benefit among patients with rheumatoid arthritis (English)
William J Shergy
Reuben A Isern
David A Cooley
John L Harshbarger
J Eugene Huffstutter
Gordon M Hughes
Elizabeth A Spencer-Smith
Allan L Goldman
Sanford H Roth
J Scott Toder
Diana Warner
Adrienne Quinn
Gregory F Keenan
Thomas F Schaible
PROMPT Study Group. Profiling Remicade Onset with MTX in a Prospective Trial